文献速递其他结缔组织病

系统性硬化症恶性肿瘤关联的临床与自身抗体特征:系统综述与荟萃分析

Clinical and autoantibody associations with malignancy in systemic sclerosis: a systematic review and meta-analysis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

结果显示男性、吸烟、肺动脉高压、间质性肺病、dcSSc、抗RNAPIII阳性及ANA阴性与恶性肿瘤风险升高相关,ACA阳性则呈负相关;抗RNAPIII与乳腺癌及早期/同期恶性肿瘤相关。作者建议对SSc患者采用风险分层监测而非统一筛查。

要点

  • 男性、吸烟、PH、ILD、dcSSc、抗RNAPIII阳性及ANA阴性与SSc恶性肿瘤风险升高相关。
  • ACA阳性与恶性肿瘤风险降低相关,尤其与肺癌负相关。
  • 抗RNAPIII与乳腺癌及SSc诊断早期/同期恶性肿瘤相关,提示风险分层监测。

核心结论

  • SSc中恶性肿瘤关联受临床表型和自身抗体谱影响,建议风险分层监测而非统一筛查。

主要发现

  • 恶性肿瘤患者发生SSc年龄更大(MD +4.01,95% CI 1.24-6.78)。
  • 与恶性肿瘤显著相关的因素包括男性(OR 1.36)、吸烟(OR 1.27)、肺动脉高压(OR 1.32)、间质性肺病(OR 1.41)、dcSSc(OR 1.14)、抗RNAPIII阳性(OR 1.79)、ACA阳性(OR 0.83)和ANA阴性(OR 1.39)。
  • 高质量研究敏感性分析中,男性、吸烟、PH和抗RNAPIII仍显著。
  • 亚组分析显示肺癌与男性(OR 2.72)、吸烟(OR 2.38)、抗拓扑异构酶I(OR 2.45)和ILD(OR 2.98)正相关,与ACA负相关(OR 0.32)。
  • 抗RNAPIII与乳腺癌(OR 2.17)及早期/同期恶性肿瘤(OR 2.85)相关,指端溃疡与后期恶性肿瘤发展相关(OR 0.39)。

临床怎么用

  • 对SSc患者应基于临床表型(男性、吸烟、PH、ILD、dcSSc)和自身抗体谱(抗RNAPIII、ACA、ANA)进行恶性肿瘤风险分层监测。
  • 抗RNAPIII阳性者需关注乳腺癌及早期/同期恶性肿瘤风险,ACA阳性者肺癌风险可能较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This meta-analysis examined factors associated with malignancy in SSc. METHODS: A systematic search of the Embase, MEDLINE and Cochrane Library databases was conducted from inception to 7 December 2024. Case-control and cohort studies reporting associations with malignancy in SSc were included. Random-effects meta-analyses were performed to pool study results. Mean differences (MDs) for age and odds ratios (ORs) for binary outcomes using frequency counts were calculated. Study quality was assessed using Newcastle-Ottawa Scale. RESULTS: Thirty-five studies comprising 27 624 SSc patients were analysed. Patients with malignancy developed SSc at an older age (MD +4.01, 95% CI 1.24-6.78). Significant associations for malignancy included male gender (OR 1.36), smoking (OR 1.27), pulmonary hypertension (PH, OR 1.32), interstitial lung disease (ILD; OR 1.41), dcSSc (OR 1.14), positive anti-RNAPIII (OR 1.79) and ACA (OR 0.83), and negative ANA (OR 1.39). In sensitivity analyses of high-quality studies, male gender, smoking, PH and anti-RNAPIII remained significant. Subgroup analyses by malignancy types and development in relation to SSc diagnosis revealed positive associations of lung malignancy with male gender (OR 2.72), smoking (OR 2.38), anti-topo I (OR 2.45) and ILD (OR 2.98), while ACA was inversely associated (OR 0.32). Anti-RNAPIII was associated with breast malignancy (OR 2.17) and early/concurrent malignancy (OR 2.85), and digital ulceration (OR 0.39) with later malignancy development. CONCLUSION: Malignancy association in SSc is influenced by clinical phenotype and autoantibody profile. Our findings suggest a risk-stratified approach to malignancy surveillance rather than uniform screening.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Raghupathy J, Teoh WS, Kanneganti A, et al. Clinical and autoantibody associations with malignancy in systemic sclerosis: a systematic review and meta-analysis. Rheumatology (Oxford). 2026. PMID: 42391056. doi:10.1093/rheumatology/keag356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。